4D Molecular Therapeutics, Inc. - Common Stock (FDMT)

4D Molecular Therapeutics Inc is a biotechnology company focused on developing innovative gene therapies that leverage its proprietary platform technology

The company aims to create targeted and effective treatment options for a range of serious diseases by designing and delivering therapeutic genes directly to specific tissues, thereby enhancing the efficacy and safety of gene-based treatments. Through its commitment to advancing molecular medicine, 4D Molecular Therapeutics works to address unmet medical needs and improve patient outcomes by harnessing the power of the body's own biology.